Medindia LOGIN REGISTER
Medindia
Advertisement

Chemotherapies Have Equal Long-term Heart Risk

by Colleen Fleiss on February 3, 2019 at 5:26 PM
Chemotherapies Have Equal Long-term Heart Risk

Cardiovascular disease is the leading cause of early death from non-cancer causes in survivors of childhood cancer.

In a new study, published in JAMA Oncology, researchers compared four chemotherapy drugs with development of cardiomyopathy (abnormal heart muscle with impaired function) years after treatment.

Advertisement


"Exposure to anthracycline chemotherapies, such as doxorubicin, has long been associated with an increased risk of cardiovascular disease in long-term childhood cancer survivors," said Gregory Aune, M.D., Ph.D., of UT Health San Antonio. "Previously, it was assumed that exposure to any member of the anthracycline class carried the same risk of late cardiovascular complications. By studying the outcomes of over 28,000 long-term survivors in the U.S. and Europe, this research indicates that exposure to different anthracyclines results in variable long-term cardiovascular risk. In the future, it will be important to take these differences into account when screening long-term survivors for cardiovascular complications and in the development of modern treatment regimens."

Mitoxantrone, another chemotherapy, appeared to have greater long-term cardiomyopathy risk than was previously estimated.

"The past several decades have been focused on devising combinations of drugs that work best for curing patients," said Gail Tomlinson, M.D., Ph.D., professor of pediatrics, division director of pediatric hematology-oncology, and holder of the Greehey Distinguished Chair in Genetics and Cancer at UT Health San Antonio. "This has been a highly successful process with a substantial increase in survival for most cancer types. Now with so many survivors alive many years from their original cancer, it is imperative to fine-tune protocols based on the goal of minimizing late effects."
Advertisement

Dr. Aune, assistant professor of pediatric hematology-oncology at UT Health San Antonio and an investigator with the university's Greehey Children's Cancer Research Institute, assisted in the study design and review. Co-authors are from the Netherlands; the Fred Hutchinson Cancer Research Center in Seattle; St. Jude Children's Research Hospital in Memphis, Tenn.; the Duke University School of Medicine; and the University of Washington, Seattle.

Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Heart Disease News

Red Flags in Red Cells  Decoding Their Threat on Heart Health!
According to health experts, an increased risk of heart attack, stroke, and blood clots is associated with higher hemoglobin levels.
Atherosclerosis in Young Adults Curbed by Early Risk Factor Management
Early cardiac evaluation reverses atherosclerosis caused by cardiac risk factors like high BP and high cholesterol in young adults.
Summer Wildfires and Winter Air Pollution Pose Varied Heart Health Risks
PM2.5 increases during winter inversions are associated with higher heart attack risk, stated study.
Genetic Testing Identifies High Cholesterol Risk, Preventing Heart Events
The study underscores the significance of broader genetic testing for familial hypercholesterolemia, a genetic disorder that causes high bad cholesterol levels.
Increased Blood Transfusion Benefits Heart Attack Patients With Anemia
For patients experiencing both anemia and a heart attack, transfusion threshold trials play a crucial role in assisting physicians in making informed decisions.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Chemotherapies Have Equal Long-term Heart Risk Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests